4-[3a-[[[2-(4,4-difluoropiperidin-1-yl)-2-oxoethyl]amino]methyl]-5a,5b,8,8,11a-pentamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,11,11b,12,13,13a,13b-tetradecahydrocyclopenta[a]chrysen-9-yl]benzoic acid

C44H62F2N2O3 — CID 78127198

IUPAC4-[3a-[[[2-(4,4-difluoropiperidin-1-yl)-2-oxoethyl]amino]methyl]-5a,5b,8,8,11a-pentamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,11,11b,12,13,13a,13b-tetradecahydrocyclopenta[a]chrysen-9-yl]benzoic acid
SMILESC=C(C)C1CCC2(CNCC(=O)N3CCC(F)(F)CC3)CCC3(C)C(CCC4C5(C)CC=C(c6ccc(C(=O)O)cc6)C(C)(C)C5CCC43C)C12
InChIInChI=1S/C44H62F2N2O3/c1-28(2)31-14-19-43(27-47-26-36(49)48-24-22-44(45,46)23-25-48)21-20-41(6)33(37(31)43)12-13-35-40(5)17-15-32(29-8-10-30(11-9-29)38(50)51)39(3,4)34(40)16-18-42(35,41)7/h8-11,15,31,33-35,37,47H,1,12-14,16-27H2,2-7H3,(H,50,51)
InChIKeyBSPAHMGVAWWYSV-UHFFFAOYSA-N
MW704.99 g/mol
LogP9.88
Rot. Bonds7

About 4-[3a-[[[2-(4,4-difluoropiperidin-1-yl)-2-oxoethyl]amino]methyl]-5a,5b,8,8,11a-pentamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,11,11b,12,13,13a,13b-tetradecahydrocyclopenta[a]chrysen-9-yl]benzoic acid

4-[3a-[[[2-(4,4-difluoropiperidin-1-yl)-2-oxoethyl]amino]methyl]-5a,5b,8,8,11a-pentamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,11,11b,12,13,13a,13b-tetradecahydrocyclopenta[a]chrysen-9-yl]benzoic acid (PubChem CID 78127198) has the molecular formula C44H62F2N2O3 and a molecular weight of 704.99 g/mol. Its IUPAC name is 4-[3a-[[[2-(4,4-difluoropiperidin-1-yl)-2-oxoethyl]amino]methyl]-5a,5b,8,8,11a-pentamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,11,11b,12,13,13a,13b-tetradecahydrocyclopenta[a]chrysen-9-yl]benzoic acid.

Molecular Properties

Compound Name4-[3a-[[[2-(4,4-difluoropiperidin-1-yl)-2-oxoethyl]amino]methyl]-5a,5b,8,8,11a-pentamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,11,11b,12,13,13a,13b-tetradecahydrocyclopenta[a]chrysen-9-yl]benzoic acid
PubChem CID78127198
Molecular FormulaC44H62F2N2O3
Molecular Weight704.99 g/mol
Exact Mass704.47
IUPAC Name4-[3a-[[[2-(4,4-difluoropiperidin-1-yl)-2-oxoethyl]amino]methyl]-5a,5b,8,8,11a-pentamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,11,11b,12,13,13a,13b-tetradecahydrocyclopenta[a]chrysen-9-yl]benzoic acid
SMILESC=C(C)C1CCC2(CNCC(=O)N3CCC(F)(F)CC3)CCC3(C)C(CCC4C5(C)CC=C(c6ccc(C(=O)O)cc6)C(C)(C)C5CCC43C)C12
InChIInChI=1S/C44H62F2N2O3/c1-28(2)31-14-19-43(27-47-26-36(49)48-24-22-44(45,46)23-25-48)21-20-41(6)33(37(31)43)12-13-35-40(5)17-15-32(29-8-10-30(11-9-29)38(50)51)39(3,4)34(40)16-18-42(35,41)7/h8-11,15,31,33-35,37,47H,1,12-14,16-27H2,2-7H3,(H,50,51)
InChIKeyBSPAHMGVAWWYSV-UHFFFAOYSA-N
XLogP9.88
TPSA69.64 Ų
H-Bond Donors2
H-Bond Acceptors3
Rotatable Bonds7
Heavy Atoms51
Complexity—

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500704.99
LogP ≤ 59.88
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 103

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'isolated_alkene', 'substructure': 'N/A'}

Analyze 4-[3a-[[[2-(4,4-difluoropiperidin-1-yl)-2-oxoethyl]amino]methyl]-5a,5b,8,8,11a-pentamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,11,11b,12,13,13a,13b-tetradecahydrocyclopenta[a]chrysen-9-yl]benzoic acid with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 4-[3a-[[[2-(4,4-difluoropiperidin-1-yl)-2-oxoethyl]amino]methyl]-5a,5b,8,8,11a-pentamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,11,11b,12,13,13a,13b-tetradecahydrocyclopenta[a]chrysen-9-yl]benzoic acid?
The IUPAC name of 4-[3a-[[[2-(4,4-difluoropiperidin-1-yl)-2-oxoethyl]amino]methyl]-5a,5b,8,8,11a-pentamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,11,11b,12,13,13a,13b-tetradecahydrocyclopenta[a]chrysen-9-yl]benzoic acid (CID 78127198) is 4-[3a-[[[2-(4,4-difluoropiperidin-1-yl)-2-oxoethyl]amino]methyl]-5a,5b,8,8,11a-pentamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,11,11b,12,13,13a,13b-tetradecahydrocyclopenta[a]chrysen-9-yl]benzoic acid.
What is the SMILES notation for 4-[3a-[[[2-(4,4-difluoropiperidin-1-yl)-2-oxoethyl]amino]methyl]-5a,5b,8,8,11a-pentamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,11,11b,12,13,13a,13b-tetradecahydrocyclopenta[a]chrysen-9-yl]benzoic acid?
The canonical SMILES for 4-[3a-[[[2-(4,4-difluoropiperidin-1-yl)-2-oxoethyl]amino]methyl]-5a,5b,8,8,11a-pentamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,11,11b,12,13,13a,13b-tetradecahydrocyclopenta[a]chrysen-9-yl]benzoic acid is C=C(C)C1CCC2(CNCC(=O)N3CCC(F)(F)CC3)CCC3(C)C(CCC4C5(C)CC=C(c6ccc(C(=O)O)cc6)C(C)(C)C5CCC43C)C12.
What is the InChIKey of 4-[3a-[[[2-(4,4-difluoropiperidin-1-yl)-2-oxoethyl]amino]methyl]-5a,5b,8,8,11a-pentamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,11,11b,12,13,13a,13b-tetradecahydrocyclopenta[a]chrysen-9-yl]benzoic acid?
The InChIKey is BSPAHMGVAWWYSV-UHFFFAOYSA-N. The full InChI is InChI=1S/C44H62F2N2O3/c1-28(2)31-14-19-43(27-47-26-36(49)48-24-22-44(45,46)23-25-48)21-20-41(6)33(37(31)43)12-13-35-40(5)17-15-32(29-8-10-30(11-9-29)38(50)51)39(3,4)34(40)16-18-42(35,41)7/h8-11,15,31,33-35,37,47H,1,12-14,16-27H2,2-7H3,(H,50,51).
What are the key properties of 4-[3a-[[[2-(4,4-difluoropiperidin-1-yl)-2-oxoethyl]amino]methyl]-5a,5b,8,8,11a-pentamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,11,11b,12,13,13a,13b-tetradecahydrocyclopenta[a]chrysen-9-yl]benzoic acid?
4-[3a-[[[2-(4,4-difluoropiperidin-1-yl)-2-oxoethyl]amino]methyl]-5a,5b,8,8,11a-pentamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,11,11b,12,13,13a,13b-tetradecahydrocyclopenta[a]chrysen-9-yl]benzoic acid has a molecular weight of 704.99 g/mol, XLogP of 9.88, 7 rotatable bonds, 2 hydrogen bond donors, and 3 hydrogen bond acceptors.
Where does this data come from?
All data for 4-[3a-[[[2-(4,4-difluoropiperidin-1-yl)-2-oxoethyl]amino]methyl]-5a,5b,8,8,11a-pentamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,11,11b,12,13,13a,13b-tetradecahydrocyclopenta[a]chrysen-9-yl]benzoic acid is sourced from PubChem (CID 78127198), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).